General Information of This Metabolic Reaction (MR) (ID:
MR009500) |
Formula |
|
Reactant |
Ranolazine |
Product |
CVT-2534 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-dealkylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions
|
2 |
Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats
|
3 |
Fatal, Intentional Overdose of Ranolazine: Post-Mortem Distribution of Parent Drug and its Major Metabolite
|
4 |
Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.